Cold Sores Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Video
• Funding
• Alerts
• Clinical Trials
• Forums

A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Relapsed/Refractory Advanced Solid Tumors
Conditions:   Lung Cancer;   Bronchial Cancer;   Non Small Cell Lung Cancer;   Small Cell Lung Cancer;   Sarcoma;   Colorectal Cancer;   Gastric Cancer;   Liver Cancer;   Breast Cancer;   Pancreatic Cancer;   Head and Neck Cancer;   Ovarian Cancer Intervention:   Drug: Recombinant oncolytic herpes simplex virus type 1 (R130) Sponsors:   Shanghai Yunying Medical Technology;   The PLA Navy Anqing Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 2, 2023 Category: Research Source Type: clinical trials